FDA Official Fires Back at UniQure, Doubles Down on Sham-Controlled Trial
✦ NabkaNews BriefAuto-summarized from multiple outlets · verify with the source
An FDA official has responded to uniQure, reiterating support for a sham-controlled trial. This has led to volatility in uniQure's stock. The exchange between the FDA and uniQure appears to be ongoing, with its impact on the company's stock being closely watched.